Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.NeurogesX to raise $25 million through private placement
The company has also issued five-year warrants to purchase 1,206,273 additional shares of its common stock at an exercise price of $8.034 per share. The warrants were purchased
The company has also issued five-year warrants to purchase 1,206,273 additional shares of its common stock at an exercise price of $8.034 per share. The warrants were purchased
Under the new partnership, the center will operate under the new name, University Ambulatory Surgery Center that will continue to operate as a multi- specialty center offering orthopedics,
The modern facility and $2 million redesign investment accommodates nSpire Health’s growing staff, implementation of lean manufacturing on new manufacturing lines, respiratory core lab facilities, customer care and
The tentative approval relates to the use of Stavzor in the treatment of manic episodes associated with bipolar disorder, monotherapy and adjunctive therapy in multiple seizure types (including
The company has until June 16, 2008 to regain compliance, which requires a closing bid price of the company’s common stock at or above $1 per share for
The purchase price consisted of 1.05 million newly issued shares of common stock of NeuroMetrix, with a value of approximately $9.9 million as of the closing of the
In this South African safety study volunteers were dosed with pafuramidine 100mg twice daily for 14 days or placebo. The subjects are undergoing close monitoring for any changes
Illumigen’s lead compound is IB657, a protein therapeutic in preclinical development for the treatment of hepatitis C virus (HCV) infections. Cubist expects that an IND for IB657 will
In the treatment of severe Alzheimer’s disease (AD), dose of Aricept is increased to 10mg once daily, after four weeks and later at 5mg. Currently, Aricept is marketed
The northern state of Kano sued Pfizer for $2 billion in damages and pressed for criminal charges over the testing of the antibiotic Trovan on children in Kano